{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:54:02Z","timestamp":1793224442027,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02287-6","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:45:14Z","timestamp":1782787514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pathway-level proteomics identifies subcellular trafficking dysregulation as a molecular signature in severe traumatic brain injury"],"prefix":"10.1007","volume":"75","author":[{"given":"Logan R.","family":"Van Nynatten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tweddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gediminas","family":"Cepinskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Basmaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Slessarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas D.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"1","key":"2287_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12883-023-03145-2","volume":"23","author":"\u00c1 R\u00e9a-Neto","year":"2023","unstructured":"R\u00e9a-Neto \u00c1, da Silva J\u00faniorED, Hassler G, Dos Santos VB, Bernardelli RS, Kozesinski-Nakatani AC, et al. Epidemiological and clinical characteristics predictive of ICU mortality of patients with traumatic brain injury treated at a trauma referral hospital\u2013a cohort study. BMC Neurol. 2023;23(1):101.","journal-title":"BMC Neurol"},{"issue":"sup1","key":"2287_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/10903120701732052","volume":"12","author":"N Badjatia","year":"2008","unstructured":"Badjatia N, Carney N, Crocco TJ, Fallat ME, Hennes HM, Jagoda AS, et al. Guidelines for prehospital management of traumatic brain injury 2nd edition. Prehosp Emerg Care. 2008;12(sup1):S1\u201352.","journal-title":"Prehosp Emerg Care"},{"issue":"1","key":"2287_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","volume":"80","author":"N Carney","year":"2017","unstructured":"Carney N, Totten AM, O\u2019Reilly C, Ullman JS, Hawryluk GW, Bell MJ, et al. Guidelines for the management of severe traumatic brain injury. Neurosurgery. 2017;80(1):6\u201315.","journal-title":"Neurosurgery"},{"issue":"3","key":"2287_CR4","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1093\/neurosurgery\/58.3.vi","volume":"58","author":"MR Bullock","year":"2006","unstructured":"Bullock MR, Chesnut R, Ghajar J, Gordon D, Hartl R, Newell DW, et al. Guidelines for the surgical management of traumatic brain injury author group: acknowledgments. Neurosurgery. 2006;58(3):S2-vi.","journal-title":"Neurosurgery"},{"issue":"23","key":"2287_CR5","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1089\/neu.2014.3352","volume":"32","author":"HM Bramlett","year":"2015","unstructured":"Bramlett HM, Dietrich WD. Long-term consequences of traumatic brain injury: current status of potential mechanisms of injury and neurological outcomes. J Neurotrauma. 2015;32(23):1834\u201348.","journal-title":"J Neurotrauma"},{"issue":"5","key":"2287_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/brainsci12050527","volume":"12","author":"Z Ahmed","year":"2022","unstructured":"Ahmed Z. Current clinical trials in traumatic brain injury. Brain Sci. 2022;12(5):527.","journal-title":"Brain Sci"},{"key":"2287_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-017-1836-5","volume":"21","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gomez H, Chang C-CH, Clermont G, Kellum JA, Kennedy J, et al. Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness. Crit Care. 2017;21:1\u201311.","journal-title":"Crit Care"},{"issue":"9","key":"2287_CR8","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1164\/rccm.201411-2125CP","volume":"192","author":"TJ Iwashyna","year":"2015","unstructured":"Iwashyna TJ, Burke JF, Sussman JB, Prescott HC, Hayward RA, Angus DC. Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care. Am J Respir Crit Care Med. 2015;192(9):1045\u201351.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"2287_CR9","doi-asserted-by":"publisher","first-page":"e2431115","DOI":"10.1001\/jamanetworkopen.2024.31115","volume":"7","author":"L Papa","year":"2024","unstructured":"Papa L, McKinley WI, Valadka AB, Newman ZC, Nordgren RK, Pramuka PE, et al. Diagnostic performance of GFAP, UCH-L1, and MAP-2 within 30 and 60 minutes of traumatic brain injury. JAMA Netw Open. 2024;7(9):e2431115\u2013e2431115.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"2287_CR10","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S1474-4422(18)30231-X","volume":"17","author":"JJ Bazarian","year":"2018","unstructured":"Bazarian JJ, Biberthaler P, Welch RD, Lewis LM, Barzo P, Bogner-Flatz V, et al. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study. Lancet Neurol. 2018;17(9):782\u20139.","journal-title":"Lancet Neurol"},{"issue":"5","key":"2287_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/jamaneurol.2016.0039","volume":"73","author":"L Papa","year":"2016","unstructured":"Papa L, Brophy GM, Welch RD, Lewis LM, Braga CF, Tan CN, et al. Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain injury. JAMA Neurol. 2016;73(5):551\u201360.","journal-title":"JAMA Neurol"},{"issue":"1","key":"2287_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/bja\/aem131","volume":"99","author":"C Werner","year":"2007","unstructured":"Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth. 2007;99(1):4\u20139.","journal-title":"Br J Anaesth"},{"key":"2287_CR13","doi-asserted-by":"crossref","unstructured":"Chakravarti B, Mallik B, Chakravarti DN. Proteomics and systems biology: application in drug discovery and development. In: Systems biology in drug discovery and development: methods and protocols. 2010;3\u201328.","DOI":"10.1007\/978-1-60761-800-3_1"},{"key":"2287_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fneur.2013.00061","volume":"4","author":"J Guingab-Cagmat","year":"2013","unstructured":"Guingab-Cagmat J, Cagmat E, Hayes RL, Anagli J. Integration of proteomics, bioinformatics, and systems biology in traumatic brain injury biomarker discovery. Front Neurol. 2013;4:61.","journal-title":"Front Neurol"},{"issue":"13","key":"2287_CR15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1089\/neu.2012.2631","volume":"30","author":"JD Feala","year":"2013","unstructured":"Feala JD, AbdulHameed MDM, Yu C, Dutta B, Yu X, Schmid K, et al. Systems biology approaches for discovering biomarkers for traumatic brain injury. J Neurotrauma. 2013;30(13):1101\u201316.","journal-title":"J Neurotrauma"},{"issue":"13-14","key":"2287_CR16","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1089\/neu.2024.0581","volume":"42","author":"JJ Bazarian","year":"2025","unstructured":"Bazarian JJ, Zetterberg H, Buki A, Dengler BA, Diaz-Arrastia R, Korley FK, et al. Blood-based biomarkers for improved characterization of traumatic brain injury: recommendations from the 2024 National Institute for Neurological Disorders and Stroke Traumatic Brain Injury Classification and Nomenclature Initiative Blood-Based Biomarkers Working Group. J Neurotrauma. 2025;42(13\u201314):1065\u201385.","journal-title":"J Neurotrauma"},{"key":"2287_CR17","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.12688\/f1000research.20445.1","volume":"8","author":"M Chen","year":"2019","unstructured":"Chen M, Soosaipillai A, Fraser DD, Diamandis EP. Discovery of novel plasma biomarker ratios to discriminate traumatic brain injury. F1000Res. 2019;8:1695.","journal-title":"F1000Res"},{"issue":"5","key":"2287_CR18","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/jalm\/jfab004","volume":"6","author":"M Chen","year":"2021","unstructured":"Chen M, Ren AH, Prassas I, Soosaipillai A, Lim B, Fraser DD, et al. Plasma protein profiling by proximity extension assay technology reveals novel biomarkers of traumatic brain injury\u2014a pilot study. J Appl Lab Med. 2021;6(5):1165\u201378.","journal-title":"J Appl Lab Med"},{"issue":"10","key":"2287_CR19","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1515\/cclm-2021-0103","volume":"59","author":"DD Fraser","year":"2021","unstructured":"Fraser DD, Chen M, Ren A, Miller MR, Martin C, Daley M, et al. Novel severe traumatic brain injury blood outcome biomarkers identified with proximity extension assay. Clin Chem Lab Med (CCLM). 2021;59(10):1662\u20139.","journal-title":"Clin Chem Lab Med (CCLM)"},{"issue":"15","key":"2287_CR20","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1093\/nar\/gkr424","volume":"39","author":"M Lundberg","year":"2011","unstructured":"Lundberg M, Eriksson A, Tran B, Assarsson E, Fredriksson S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res. 2011;39(15):e102.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2287_CR21","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bj\u00f6rkesten J, Thorsen SB, Ekman D, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. 2014;9(4):e95192.","journal-title":"PLoS ONE"},{"issue":"1","key":"2287_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1474-4422(23)00358-7","volume":"23","author":"CA \u00c5kerlund","year":"2024","unstructured":"\u00c5kerlund CA, Holst A, Bhattacharyay S, Stocchetti N, Steyerberg E, Smielewski P, et al. Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): a multicentre observational cohort study. Lancet Neurol. 2024;23(1):71\u201380.","journal-title":"Lancet Neurol"},{"issue":"26","key":"2287_CR23","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1056\/NEJMoa1404304","volume":"371","author":"DW Wright","year":"2014","unstructured":"Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, et al. Very early administration of progesterone for acute traumatic brain injury. N Engl J Med. 2014;371(26):2457\u201366.","journal-title":"N Engl J Med"},{"issue":"26","key":"2287_CR24","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1411090","volume":"371","author":"BE Skolnick","year":"2014","unstructured":"Skolnick BE, Maas AI, Narayan RK, Van Der Hoop RG, MacAllister T, Ward JD, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014;371(26):2467\u201376.","journal-title":"N Engl J Med"},{"issue":"8","key":"2287_CR25","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa2404360","volume":"391","author":"AF Turgeon","year":"2024","unstructured":"Turgeon AF, Fergusson DA, Clayton L, Patton M-P, Neveu X, Walsh TS, et al. Liberal or restrictive transfusion strategy in patients with traumatic brain injury. N Engl J Med. 2024;391(8):722\u201335.","journal-title":"N Engl J Med"},{"issue":"10210","key":"2287_CR26","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","volume":"394","author":"T Crash","year":"2019","unstructured":"Crash T. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019;394(10210):1713\u201323.","journal-title":"Lancet"},{"issue":"21\u201322","key":"2287_CR27","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1089\/neu.2023.0135","volume":"40","author":"P Ciryam","year":"2023","unstructured":"Ciryam P, Gerzanich V, Simard JM. Interleukin-6 in traumatic brain injury: a Janus-faced player in damage and repair. J Neurotrauma. 2023;40(21\u201322):2249\u201369.","journal-title":"J Neurotrauma"},{"key":"2287_CR28","doi-asserted-by":"publisher","first-page":"1432217","DOI":"10.3389\/fneur.2024.1432217","volume":"15","author":"A-C Chiollaz","year":"2024","unstructured":"Chiollaz A-C, Pouillard V, Habre C, Seiler M, Romano F, Spigariol F, et al. Diagnostic potential of IL6 and other blood-based inflammatory biomarkers in mild traumatic brain injury among children. Front Neurol. 2024;15:1432217.","journal-title":"Front Neurol"},{"issue":"1","key":"2287_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12028-018-0522-z","volume":"30","author":"C Casault","year":"2019","unstructured":"Casault C, Al Sultan AS, Banoei M, Couillard P, Kramer A, Winston BW. Cytokine responses in severe traumatic brain injury: where there is smoke, is there fire? Neurocrit Care. 2019;30(1):22\u201332.","journal-title":"Neurocrit Care"},{"issue":"2","key":"2287_CR30","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/jcbfm.2010.142","volume":"31","author":"A Helmy","year":"2011","unstructured":"Helmy A, Carpenter KL, Menon DK, Pickard JD, Hutchinson PJ. The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J Cereb Blood Flow Metab. 2011;31(2):658\u201370.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"38","key":"2287_CR31","doi-asserted-by":"publisher","first-page":"e22363","DOI":"10.1097\/MD.0000000000022363","volume":"99","author":"W Gao","year":"2020","unstructured":"Gao W, Zhang Z, Lv X, Wu Q, Yan J, Mao G, et al. Neurofilament light chain level in traumatic brain injury: a system review and meta-analysis. Medicine. 2020;99(38):e22363.","journal-title":"Medicine"},{"issue":"6","key":"2287_CR32","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1212\/WNL.0000000000009983","volume":"95","author":"P Shahim","year":"2020","unstructured":"Shahim P, Politis A, Van Der Merwe A, Moore B, Chou Y-Y, Pham DL, et al. Neurofilament light as a biomarker in traumatic brain injury. Neurology. 2020;95(6):e610\u201322.","journal-title":"Neurology"},{"issue":"5","key":"2287_CR33","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/ane.13394","volume":"143","author":"D Schranz","year":"2021","unstructured":"Schranz D, Molnar T, Erdo-Bonyar S, Simon D, Berki T, Nagy C, et al. Increased level of LIGHT\/TNFSF14 is associated with survival in aneurysmal subarachnoid hemorrhage. Acta Neurol Scand. 2021;143(5):530\u20137.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"2287_CR34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12974-023-02912-9","volume":"20","author":"A Angerfors","year":"2023","unstructured":"Angerfors A, Br\u00e4nnmark C, Lagging C, Tai K, M\u00e5nsby Svedberg R, Andersson B, et al. Proteomic profiling identifies novel inflammation-related plasma proteins associated with ischemic stroke outcome. J Neuroinflamm. 2023;20(1):224.","journal-title":"J Neuroinflamm"},{"issue":"1","key":"2287_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4049\/jimmunol.1203016","volume":"191","author":"P Mana","year":"2013","unstructured":"Mana P, Linares D, Silva DG, Fordham S, Scheu S, Pfeffer K, et al. LIGHT (TNFSF14\/CD258) is a decisive factor for recovery from experimental autoimmune encephalomyelitis. J Immunol. 2013;191(1):154\u201363.","journal-title":"J Immunol"},{"key":"2287_CR36","doi-asserted-by":"publisher","first-page":"1025286","DOI":"10.3389\/fimmu.2022.1025286","volume":"13","author":"M Han","year":"2022","unstructured":"Han M, Sun Y, Zhao W, Xiang G, Wang X, Jiang Z, et al. Comprehensive characterization of TNFSF14\/LIGHT with implications in prognosis and immunotherapy of human gliomas. Front Immunol. 2022;13:1025286.","journal-title":"Front Immunol"},{"issue":"6","key":"2287_CR37","doi-asserted-by":"publisher","first-page":"588","DOI":"10.2183\/pjab.86.588","volume":"86","author":"T Nakamura","year":"2010","unstructured":"Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad B. 2010;86(6):588\u2013610.","journal-title":"Proc Jpn Acad B"},{"issue":"2","key":"2287_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0165-3806(97)00108-9","volume":"102","author":"C Achim","year":"1997","unstructured":"Achim C, Katyal S, Wiley C, Shiratori M, Wang G, Oshika E, et al. Expression of HGF and cMet in the developing and adult brain. Dev Brain Res. 1997;102(2):299\u2013303.","journal-title":"Dev Brain Res"},{"key":"2287_CR39","doi-asserted-by":"publisher","first-page":"683609","DOI":"10.3389\/fcell.2021.683609","volume":"9","author":"C Desole","year":"2021","unstructured":"Desole C, Gallo S, Vitacolonna A, Montarolo F, Bertolotto A, Vivien D, et al. HGF and MET: from brain development to neurological disorders. Front Cell Dev Biol. 2021;9:683609.","journal-title":"Front Cell Dev Biol"},{"key":"2287_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111867","author":"R Rehman","year":"2022","unstructured":"Rehman R, Miller M, Krishnamurthy SS, Kjell J, Elsayed L, Hauck SM, et al. Met\/HGFR triggers detrimental reactive microglia in TBI. Cell Rep. 2022. https:\/\/doi.org\/10.1016\/j.celrep.2022.111867.","journal-title":"Cell Rep"},{"issue":"6","key":"2287_CR41","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.immuni.2015.10.017","volume":"43","author":"MM Guerrini","year":"2015","unstructured":"Guerrini MM, Okamoto K, Komatsu N, Sawa S, Danks L, Penninger JM, et al. Inhibition of the TNF family cytokine RANKL prevents autoimmune inflammation in the central nervous system. Immunity. 2015;43(6):1174\u201385.","journal-title":"Immunity"},{"issue":"4","key":"2287_CR42","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1176\/jnp.2007.19.4.363","volume":"19","author":"MS Rothman","year":"2007","unstructured":"Rothman MS, Arciniegas DB, Filley CM, Wierman ME. The neuroendocrine effects of traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2007;19(4):363\u201372.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"2287_CR43","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1046\/j.1460-9568.1998.00064.x","volume":"10","author":"SY Roe","year":"1998","unstructured":"Roe SY, McGowan EM, Rothwell NJ. Evidence for the involvement of corticotrophin-releasing hormone in the pathogenesis of traumatic brain injury. Eur J Neurosci. 1998;10(2):553\u20139.","journal-title":"Eur J Neurosci"},{"issue":"6","key":"2287_CR44","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1097\/TA.0b013e318156ee4c","volume":"63","author":"MJ Cohen","year":"2007","unstructured":"Cohen MJ, Brohi K, Ganter MT, Manley GT, Mackersie RC, Pittet J-F. Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the Protein C pathway. J Trauma Acute Care Surg. 2007;63(6):1254\u201362.","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"2287_CR45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s12975-011-0125-x","volume":"2","author":"A Chodobski","year":"2011","unstructured":"Chodobski A, Zink BJ, Szmydynger-Chodobska J. Blood\u2013brain barrier pathophysiology in traumatic brain injury. Transl Stroke Res. 2011;2(4):492\u2013516.","journal-title":"Transl Stroke Res"},{"key":"2287_CR46","doi-asserted-by":"crossref","unstructured":"Dardiotis E, Karanikas V, Paterakis K, Fountas K, Hadjigeorgiou GM. Traumatic brain injury and inflammation: emerging role of innate and adaptive immunity. In: Brain Injury\u2013pathogenesis, monitoring, recovery and management. 2012;23\u201338.","DOI":"10.5772\/27840"},{"issue":"5","key":"2287_CR47","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1089\/neu.2006.0229","volume":"24","author":"WO Opii","year":"2007","unstructured":"Opii WO, Nukala VN, Sultana R, Pandya JD, Day KM, Merchant ML, et al. Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury. J Neurotrauma. 2007;24(5):772\u201389.","journal-title":"J Neurotrauma"},{"issue":"10","key":"2287_CR48","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1074\/mcp.M600157-MCP200","volume":"5","author":"FH Kobeissy","year":"2006","unstructured":"Kobeissy FH, Ottens AK, Zhang Z, Liu MC, Denslow ND, Dave JR, et al. Novel differential neuroproteomics analysis of traumatic brain injury in rats. Mol Cell Proteomics. 2006;5(10):1887\u201398.","journal-title":"Mol Cell Proteomics"},{"issue":"12","key":"2287_CR49","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.4161\/15548627.2014.981787","volume":"10","author":"C Sarkar","year":"2014","unstructured":"Sarkar C, Zhao Z, Aungst S, Sabirzhanov B, Faden AI, Lipinski MM. Impaired autophagy flux is associated with neuronal cell death after traumatic brain injury. Autophagy. 2014;10(12):2208\u201322.","journal-title":"Autophagy"},{"issue":"4","key":"2287_CR50","doi-asserted-by":"publisher","first-page":"e12734","DOI":"10.1002\/rth2.12734","volume":"6","author":"WB Hubbard","year":"2022","unstructured":"Hubbard WB, Sim MM, Saatman KE, Sullivan PG, Wood JP. Tissue factor release following traumatic brain injury drives thrombin generation. Res Pract Thromb Haemost. 2022;6(4):e12734.","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"2287_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ncb1342","volume":"8","author":"OO Glebov","year":"2006","unstructured":"Glebov OO, Bright NA, Nichols BJ. Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat Cell Biol. 2006;8(1):46\u201354.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2287_CR52","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s44341-025-00020-8","volume":"2","author":"G Kang","year":"2025","unstructured":"Kang G, Moo EK, Banton R, Petel OE, Harris AR. Cellular mechanisms of traumatic brain injury. npj Biol Phys Mech. 2025;2(1):16.","journal-title":"npj Biol Phys Mech"},{"issue":"12","key":"2287_CR53","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1523\/JNEUROSCI.5119-05.2006","volume":"26","author":"O Farkas","year":"2006","unstructured":"Farkas O, Lifshitz J, Povlishock JT. Mechanoporation induced by diffuse traumatic brain injury: an irreversible or reversible response to injury? J Neurosci. 2006;26(12):3130\u201340.","journal-title":"J Neurosci"},{"key":"2287_CR54","first-page":"6","volume":"1","author":"OJ Castej\u00f3n","year":"2008","unstructured":"Castej\u00f3n OJ, de Castej\u00f3n HV. Ultrastructural pathology of Golgi apparatus of nerve cells in human brain edema. Biomed J. 2008;1:6.","journal-title":"Biomed J"},{"issue":"1","key":"2287_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40659-021-00329-3","volume":"54","author":"M Lira","year":"2021","unstructured":"Lira M, Zamorano P, Cerpa W. Exo70 intracellular redistribution after repeated mild traumatic brain injury. Biol Res. 2021;54(1):5.","journal-title":"Biol Res"},{"issue":"5","key":"2287_CR56","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/cells10051009","volume":"10","author":"D Qin","year":"2021","unstructured":"Qin D, Wang J, Le A, Wang TJ, Chen X, Wang J. Traumatic brain injury: ultrastructural features in neuronal ferroptosis, glial cell activation and polarization, and blood\u2013brain barrier breakdown. Cells. 2021;10(5):1009.","journal-title":"Cells"},{"issue":"2","key":"2287_CR57","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41419-024-06515-x","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang Y, Lu D, Wang M, Liu G, Feng Y, Ren Y, et al. Endoplasmic reticulum stress and the unfolded protein response: emerging regulators in progression of traumatic brain injury. Cell Death Dis. 2024;15(2):156.","journal-title":"Cell Death Dis"},{"key":"2287_CR58","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3389\/fphar.2020.00629","volume":"11","author":"A Kumar","year":"2020","unstructured":"Kumar A, Ahmad A, Vyawahare A, Khan R. Membrane trafficking and subcellular drug targeting pathways. Front Pharmacol. 2020;11:629.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2287_CR59","first-page":"311","volume":"28","author":"S Ekmark-Lew\u00e9n","year":"2010","unstructured":"Ekmark-Lew\u00e9n S, Lew\u00e9n A, Israelsson C, Li GL, Farooque M, Olsson Y, et al. Vimentin and GFAP responses in astrocytes after contusion trauma to the murine brain. Restor Neurol Neurosci. 2010;28(3):311\u201321.","journal-title":"Restor Neurol Neurosci"},{"issue":"2","key":"2287_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/neup.12158","volume":"35","author":"CA Wiley","year":"2015","unstructured":"Wiley CA, Bonneh-Barkay D, Dixon CE, Lesniak A, Wang G, Bissel SJ, et al. Role for mammalian Chitinase 3-like protein 1 in traumatic brain injury. Neuropathology. 2015;35(2):95\u2013106.","journal-title":"Neuropathology"},{"issue":"6","key":"2287_CR61","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/jnc.15824","volume":"165","author":"F Li","year":"2023","unstructured":"Li F, Liu A, Zhao M, Luo L. Astrocytic Chitinase-3-like protein 1 in neurological diseases: potential roles and future perspectives. J Neurochem. 2023;165(6):772\u201390.","journal-title":"J Neurochem"},{"issue":"1","key":"2287_CR62","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/CCM.0b013e318298a890","volume":"42","author":"S Prathep","year":"2014","unstructured":"Prathep S, Sharma D, Hallman M, Joffe A, Krishnamoorthy V, Mackensen GB, et al. Preliminary report on cardiac dysfunction after isolated traumatic brain injury. Crit Care Med. 2014;42(1):142\u20137.","journal-title":"Crit Care Med"},{"issue":"4","key":"2287_CR63","first-page":"622","volume":"116","author":"S Ryan","year":"1994","unstructured":"Ryan S, Sandler A, Trenhaile S, Ephgrave K, Garner S. Pancreatic enzyme elevations after blunt trauma. Surgery. 1994;116(4):622\u20137.","journal-title":"Surgery"},{"issue":"2","key":"2287_CR64","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00018-007-7288-3","volume":"65","author":"Y Wang","year":"2008","unstructured":"Wang Y, Luo W, Reiser G. Trypsin and trypsin-like proteases in the brain: proteolysis and cellular functions. Cell Mol Life Sci. 2008;65(2):237\u201352.","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"2287_CR65","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0166-2236(00)01617-9","volume":"23","author":"MB Gingrich","year":"2000","unstructured":"Gingrich MB, Traynelis SF. Serine proteases and brain damage\u2013is there a link? Trends Neurosci. 2000;23(9):399\u2013407.","journal-title":"Trends Neurosci"},{"issue":"3","key":"2287_CR66","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3171\/jns.1979.51.3.0307","volume":"51","author":"PR Cooper","year":"1979","unstructured":"Cooper PR, Moody S, Clark WK, Kirkpatrick J, Maravilla K, Gould AL, et al. Dexamethasone and severe head injury: a prospective double-blind study. J Neurosurg. 1979;51(3):307\u201316.","journal-title":"J Neurosurg"},{"key":"2287_CR67","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/2152-7806.190439","volume":"7","author":"R Hoshide","year":"2016","unstructured":"Hoshide R, Cheung V, Marshall L, Kasper E, Chen CC. Do corticosteroids play a role in the management of traumatic brain injury? Surg Neurol Int. 2016;7:84.","journal-title":"Surg Neurol Int"},{"issue":"3","key":"2287_CR68","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3171\/jns.1983.58.3.0326","volume":"58","author":"R Braakman","year":"1983","unstructured":"Braakman R, Schouten HJ, Blaauw-van Dishoeck M, Minderhoud JM. Megadose steroids in severe head injury: results of a prospective double-blind clinical trial. J Neurosurg. 1983;58(3):326\u201330.","journal-title":"J Neurosurg"},{"issue":"1","key":"2287_CR69","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF02576791","volume":"195","author":"T Grumme","year":"1995","unstructured":"Grumme T, Baethmann A, Kolodziejczyk D, Krimmer J, Fischer M, Rothe BvE, et al. Treatment of patients with severe head injury by triamcinolone: a prospective, controlled multicenter clinical trial of 396 cases. Res Exp Med. 1995;195(1):217\u201329.","journal-title":"Res Exp Med"},{"issue":"9442","key":"2287_CR70","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0140-6736(04)17188-2","volume":"364","author":"Collaborators CT","year":"2004","unstructured":"Collaborators CT. Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004;364(9442):1321\u20138.","journal-title":"Lancet"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02287-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02287-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02287-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:21:02Z","timestamp":1782793262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02287-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2287"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02287-6","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study was approved by the Western University, Human Research Ethics Board (REB #s 6970; #100036; # 6963). Our experimental methods are performed in accordance with ethical standards of the responsible committee on human experimentation with the Helsinki Declaration of 1975. Informed written consent was obtained from either participants or their substitute decision makers.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"162"}}